SCHEMBL1885577

SCHEMBL1885577

Cc1c(C(N)=O)cccc1-c1ccc(C(F)(F)F)cc1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 3/20 0.50
▸ JAK2 O60674 1/20 0.46
▸ BCAT2 O15382 1/20 0.45
▸ CASP1 P29466 1/20 0.45
▸ DHODH Q02127 1/20 0.44
▸ KIF11 P52732 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ BACE1 P56817 1/20 0.43
▸ KLRK1 P26718 3/20 0.42
▸ MICA Q29983 3/20 0.42
▸ RAET1L Q5VY80 3/20 0.42
▸ LCK P06239 1/20 0.42
▸ GAA P10253 1/20 0.41
▸ SCN9A Q15858 1/20 0.41
▸ CYP2C8 P10632 1/20 0.41
▸ APP P05067 1/20 0.40
▸ PDK2 Q15119 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2745460 0.86 CYP2C8 (0.49) KIF11ALDH1A1SMN1; SMN2BACE1KLRK1
SCHEMBL2564888 0.84 BCAT2 (0.65) PARP1BCAT2CASP1KIF11KDM4E
SCHEMBL17803632 0.83 SLC6A4 (0.51) JAK2BCAT2DHODH
SCHEMBL27906241 0.83 BCAT2 (0.62) PARP1BCAT2CASP1DHODHKIF11
SCHEMBL28262741 0.82 PARP1 (0.48) PARP1JAK2BCAT2CASP1DHODH
SCHEMBL29917415 0.82 SLC6A3 (0.52) KDM4EBACE1KLRK1MICARAET1L
Trifluoroacetic Acid SCHEMBL1785126 0.82 BCAT2 (0.57) PARP1BCAT2SMN1; SMN2PDK2
SCHEMBL14813212 0.81 CHEK1 (0.49) BCAT2SCN9A
SCHEMBL29941849 0.81 MKNK1 (0.55) PARP1BCAT2
SCHEMBL30034930 0.80 BCAT2 (0.69) PARP1BCAT2KDM4EALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2501370-A1 METHODS AND COMPOSITIONS FOR TREATING SOLID TUMORS AND OTHER MALIGNANCIES Novartis AG (CH) 2012-09-26 — — EP disclosed
WO-2011062939-A1 METHODS AND COMPOSITIONS FOR TREATING SOLID TUMORS AND OTHER MALIGNANCIES NOVARTIS AG (CH) 2011-05-26 — — WO disclosed
Send feedback